[HTML][HTML] Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis
NF Maranchick, CA Peloquin - Journal of Clinical Tuberculosis and Other …, 2024 - Elsevier
Tuberculosis (TB) is a leading cause of mortality worldwide, and resistance to anti-
tuberculosis drugs is a challenge to effective treatment. Multi-drug resistant TB (MDR-TB) …
tuberculosis drugs is a challenge to effective treatment. Multi-drug resistant TB (MDR-TB) …
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Y Zhu, L Zhu, L Davies Forsman, J Paues… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Although cycloserine is a recommended drug for the treatment of multidrug-resistant
tuberculosis (MDR-TB) according to World Health Organization (WHO), few studies have …
tuberculosis (MDR-TB) according to World Health Organization (WHO), few studies have …
Interaction of Host Pattern Recognition Receptors (PRRs) with Mycobacterium Tuberculosis and Ayurvedic Management of Tuberculosis: A Systemic Approach
N Ponnusamy, M Arumugam - Infectious Disorders-Drug …, 2022 - benthamdirect.com
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb),
infects the lungs' alveolar surfaces through aerosol droplets. At this stage, the disease …
infects the lungs' alveolar surfaces through aerosol droplets. At this stage, the disease …
Pharmacokinetic modeling, simulation, and development of a limited sampling strategy of cycloserine in patients with multidrug-/extensively drug-resistant tuberculosis
R van Der Galiën, N Boveneind-Vrubleuskaya… - Clinical …, 2020 - Springer
Abstract Background and Objective Multidrug-resistant tuberculosis has much poorer
treatment outcomes compared with drug-susceptible tuberculosis because second-line …
treatment outcomes compared with drug-susceptible tuberculosis because second-line …
[HTML][HTML] Inhibiting De Novo Biosynthesis of Ceramide by L-Cycloserine Can Prevent Light-Induced Retinal Degeneration in Albino BALB/c Mice
F Tahia, D Ma, DJ Stephenson, SK Basu… - International Journal of …, 2024 - mdpi.com
Retinal degenerative diseases lead to irreversible vision loss due to photoreceptor cell
death, driven by complex genetic and environmental factors. Ceramide, a sphingolipid …
death, driven by complex genetic and environmental factors. Ceramide, a sphingolipid …
Treatment outcomes and adverse drug effects of ethambutol, cycloserine, and terizidone for the treatment of multidrug-resistant tuberculosis in South Africa
ML Van der Walt, K Shean, P Becker… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) patients receiving
ethambutol, cycloserine, or terizidone as part of a standardized regimen were compared …
ethambutol, cycloserine, or terizidone as part of a standardized regimen were compared …
[HTML][HTML] Influence of anti-tuberculosis drugs plus cycloserine on sputum negative conversion rate, adverse reactions and inflammatory factors in multi-drug resistant …
W Gao, N Yang, X Mei, X Zhu, W Hu… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: The aim of this investigation was to determine the influence of anti-tuberculosis
(anti-TB) drugs plus cycloserine (CS) on the sputum negative conversion rate, adverse …
(anti-TB) drugs plus cycloserine (CS) on the sputum negative conversion rate, adverse …
Current Drug Delivery Strategies to Design Orally Dissolving Formulations to Target Tuberculosis: A Futuristic Review
All the standard anti-tubercular drugs, well established as standard therapy, are
preferentially available in formulations compliant with the young adult population. However …
preferentially available in formulations compliant with the young adult population. However …
Natural Product-Based Treatment for Tuberculosis
G Prusty, SR Panda, RR Behera, SL Bhushan… - Natural Products for …, 2024 - Springer
Tuberculosis (TB), caused by the bacterial organism Mycobacterium tuberculosis, has
remained a persistent global health challenge, profoundly impacted millions of lives and …
remained a persistent global health challenge, profoundly impacted millions of lives and …
[HTML][HTML] Case report on cycloserine serum levels after treatment with oral terizidone and oral cycloserine
L Rose, J Thompson, L Berry, P Venkatesan - Clinical Infection in Practice, 2024 - Elsevier
A 24 year old man with multi-drug resistant pulmonary tuberculosis was treated with a
regime that included terizidone and then cycloserine. Serum drug levels of cycloserine were …
regime that included terizidone and then cycloserine. Serum drug levels of cycloserine were …